NCT06698679View on ClinicalTrials.gov

The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

November 15, 2024

Primary Completion Date

June 30, 2031

Study Completion Date

October 31, 2031

Conditions
Breast Cancer
Interventions
OTHER

No intervention

There is no intervention in this study. We will obtain blood from the recruited patients and assess the metabolites therein. This is an observational work.

Trial Locations (1)

110004

RECRUITING

Shengjing Hospital of China Medical University, Shenyang

All Listed Sponsors
lead

Shengjing Hospital

OTHER